What is he best known for?
The fields of study he is best known for:
- Enzyme
- Gene
- Internal medicine
José Luis Pedraz mainly investigates Nanotechnology, Drug delivery, Cell encapsulation, Immunology and Pharmacology.
The study incorporates disciplines such as Regenerative medicine and Cell transplantation in addition to Nanotechnology.
His Drug delivery study combines topics from a wide range of disciplines, such as Drug and Treatment duration.
His Cell encapsulation research includes themes of Fibroblast, Cell culture and Risk analysis.
His study in Immunology is interdisciplinary in nature, drawing from both Stem cell and Cell therapy.
The various areas that José Luis Pedraz examines in his Pharmacology study include Nanoparticle and In vivo.
His most cited work include:
- Cell encapsulation: promise and progress. (496 citations)
- Biomaterials for promoting brain protection, repair and regeneration. (316 citations)
- History, challenges and perspectives of cell microencapsulation (289 citations)
What are the main themes of his work throughout his whole career to date?
His main research concerns Drug delivery, Nanotechnology, In vivo, Pharmacology and Cell encapsulation.
His research integrates issues of Clinical trial and Drug in his study of Drug delivery.
His research in In vivo intersects with topics in In vitro, Surgery, Transfection and Microbiology.
His studies deal with areas such as Immunology and Antigen as well as Pharmacology.
The concepts of his Cell encapsulation study are interwoven with issues in Erythropoietin and Cell therapy.
His Cell study combines topics in areas such as Immune system, Biomedical engineering and Cell biology.
He most often published in these fields:
- Drug delivery (21.07%)
- Nanotechnology (20.31%)
- In vivo (14.94%)
What were the highlights of his more recent work (between 2018-2021)?
- Nanotechnology (20.31%)
- Drug delivery (21.07%)
- Tissue engineering (8.05%)
In recent papers he was focusing on the following fields of study:
The scientist’s investigation covers issues in Nanotechnology, Drug delivery, Tissue engineering, Cell biology and Niosome.
His Nanotechnology research includes elements of Oxide and Force spectroscopy.
His Drug delivery study incorporates themes from Clinical trial, Small interfering RNA, Cell encapsulation, Aptamer and Pulmonary surfactant.
His Cell encapsulation research incorporates elements of Treatment options, Cell therapy and Bioinformatics.
His Tissue engineering research is multidisciplinary, incorporating elements of Regenerative medicine, Biocompatibility, Biomaterial, Self-healing hydrogels and Gelatin.
His Niosome study also includes fields such as
- Gene delivery and related Viral vector, In vitro and In situ,
- Transfection and related Genetic enhancement, In vivo and Cystic fibrosis.
Between 2018 and 2021, his most popular works were:
- Beneficial effects of n-3 polyunsaturated fatty acids administration in a partial lesion model of Parkinson's disease: The role of glia and NRf2 regulation. (35 citations)
- Cationic Niosomes as Non-Viral Vehicles for Nucleic Acids: Challenges and Opportunities in Gene Delivery. (21 citations)
- Graphene oxide and reduced graphene oxide-based scaffolds in regenerative medicine. (20 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Gene
- Internal medicine
His primary areas of investigation include Tissue engineering, Drug delivery, Nanotechnology, Regenerative medicine and Gelatin.
His Tissue engineering research is multidisciplinary, relying on both Biocompatibility, Self-healing hydrogels and Cell biology.
His Self-healing hydrogels research integrates issues from Force spectroscopy, Polymer, Membrane, Genipin and Coating.
José Luis Pedraz combines subjects such as Liposome, Small interfering RNA, Pulmonary surfactant, Combinatorial chemistry and Cationic polymerization with his study of Drug delivery.
His work carried out in the field of Regenerative medicine brings together such families of science as Biomaterial, Oxide, Phase and Graphene.
His Gelatin research is multidisciplinary, incorporating perspectives in Tendon, Bone tissue, Regeneration, Mesenchymal stem cell and Bone morphogenetic protein.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
